• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. PROFEMUR(R) MODULAR FEMORAL NECK; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. PROFEMUR(R) MODULAR FEMORAL NECK; HIP COMPONENT Back to Search Results
Model Number PHA0-1252
Device Problems Naturally Worn (2988); Insufficient Information (3190)
Patient Problems Pain (1994); Osteolysis (2377); Reaction (2414)
Event Type  Injury  
Manufacturer Narrative
This complaint will be updated once investigation is complete.Trends will be evaluated.
 
Event Description
Allegedly the patient was revised due to pain.
 
Manufacturer Narrative
Additional information received on 05/08/2019 that adds patient and/or device codes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROFEMUR(R) MODULAR FEMORAL NECK
Type of Device
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key7451110
MDR Text Key106180495
Report Number3010536692-2018-00458
Device Sequence Number1
Product Code LWJ
Combination Product (y/n)N
PMA/PMN Number
K003016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup
Report Date 02/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model NumberPHA0-1252
Device Catalogue NumberPHA0-1252
Device Lot Number1558800
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date04/13/2018
Initial Date Manufacturer Received 04/13/2018
Initial Date FDA Received04/23/2018
Supplement Dates Manufacturer Received04/13/2018
04/13/2018
Supplement Dates FDA Received10/04/2019
02/24/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-